Copyright Reports & Markets. All rights reserved.

Global Solid Tumor Therapeutics Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Solid Tumor Therapeutics Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Chemotherapy
      • 1.4.3 Hormone Therapy
      • 1.4.4 Immunotherapy
      • 1.4.5 Targeted Therapy
    • 1.5 Market by Application
      • 1.5.1 Global Solid Tumor Therapeutics Market Share by Application (2014-2025)
      • 1.5.2 Breast Cancer
      • 1.5.3 Lung Cancer
      • 1.5.4 Colorectal Cancer
      • 1.5.5 Prostate Cancer
      • 1.5.6 Cervical Cancer
      • 1.5.7 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Solid Tumor Therapeutics Market Size
    • 2.2 Solid Tumor Therapeutics Growth Trends by Regions
      • 2.2.1 Solid Tumor Therapeutics Market Size by Regions (2014-2025)
      • 2.2.2 Solid Tumor Therapeutics Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Solid Tumor Therapeutics Market Size by Manufacturers
      • 3.1.1 Global Solid Tumor Therapeutics Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Solid Tumor Therapeutics Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Solid Tumor Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Solid Tumor Therapeutics Key Players Head office and Area Served
    • 3.3 Key Players Solid Tumor Therapeutics Product/Solution/Service
    • 3.4 Date of Enter into Solid Tumor Therapeutics Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Solid Tumor Therapeutics Market Size by Type (2014-2019)
    • 4.2 Global Solid Tumor Therapeutics Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Solid Tumor Therapeutics Market Size (2014-2019)
    • 5.2 Solid Tumor Therapeutics Key Players in United States
    • 5.3 United States Solid Tumor Therapeutics Market Size by Type
    • 5.4 United States Solid Tumor Therapeutics Market Size by Application

    6 Europe

    • 6.1 Europe Solid Tumor Therapeutics Market Size (2014-2019)
    • 6.2 Solid Tumor Therapeutics Key Players in Europe
    • 6.3 Europe Solid Tumor Therapeutics Market Size by Type
    • 6.4 Europe Solid Tumor Therapeutics Market Size by Application

    7 China

    • 7.1 China Solid Tumor Therapeutics Market Size (2014-2019)
    • 7.2 Solid Tumor Therapeutics Key Players in China
    • 7.3 China Solid Tumor Therapeutics Market Size by Type
    • 7.4 China Solid Tumor Therapeutics Market Size by Application

    8 Japan

    • 8.1 Japan Solid Tumor Therapeutics Market Size (2014-2019)
    • 8.2 Solid Tumor Therapeutics Key Players in Japan
    • 8.3 Japan Solid Tumor Therapeutics Market Size by Type
    • 8.4 Japan Solid Tumor Therapeutics Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Solid Tumor Therapeutics Market Size (2014-2019)
    • 9.2 Solid Tumor Therapeutics Key Players in Southeast Asia
    • 9.3 Southeast Asia Solid Tumor Therapeutics Market Size by Type
    • 9.4 Southeast Asia Solid Tumor Therapeutics Market Size by Application

    10 India

    • 10.1 India Solid Tumor Therapeutics Market Size (2014-2019)
    • 10.2 Solid Tumor Therapeutics Key Players in India
    • 10.3 India Solid Tumor Therapeutics Market Size by Type
    • 10.4 India Solid Tumor Therapeutics Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Solid Tumor Therapeutics Market Size (2014-2019)
    • 11.2 Solid Tumor Therapeutics Key Players in Central & South America
    • 11.3 Central & South America Solid Tumor Therapeutics Market Size by Type
    • 11.4 Central & South America Solid Tumor Therapeutics Market Size by Application

    12 International Players Profiles

    • 12.1 Hoffmann-La Roche
      • 12.1.1 Hoffmann-La Roche Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Solid Tumor Therapeutics Introduction
      • 12.1.4 Hoffmann-La Roche Revenue in Solid Tumor Therapeutics Business (2014-2019)
      • 12.1.5 Hoffmann-La Roche Recent Development
    • 12.2 Johnson & Johnson
      • 12.2.1 Johnson & Johnson Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Solid Tumor Therapeutics Introduction
      • 12.2.4 Johnson & Johnson Revenue in Solid Tumor Therapeutics Business (2014-2019)
      • 12.2.5 Johnson & Johnson Recent Development
    • 12.3 Novartis
      • 12.3.1 Novartis Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Solid Tumor Therapeutics Introduction
      • 12.3.4 Novartis Revenue in Solid Tumor Therapeutics Business (2014-2019)
      • 12.3.5 Novartis Recent Development
    • 12.4 AstraZeneca
      • 12.4.1 AstraZeneca Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Solid Tumor Therapeutics Introduction
      • 12.4.4 AstraZeneca Revenue in Solid Tumor Therapeutics Business (2014-2019)
      • 12.4.5 AstraZeneca Recent Development
    • 12.5 Biogen Idec
      • 12.5.1 Biogen Idec Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Solid Tumor Therapeutics Introduction
      • 12.5.4 Biogen Idec Revenue in Solid Tumor Therapeutics Business (2014-2019)
      • 12.5.5 Biogen Idec Recent Development
    • 12.6 Boehringer Ingelheim
      • 12.6.1 Boehringer Ingelheim Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Solid Tumor Therapeutics Introduction
      • 12.6.4 Boehringer Ingelheim Revenue in Solid Tumor Therapeutics Business (2014-2019)
      • 12.6.5 Boehringer Ingelheim Recent Development
    • 12.7 GlaxoSmithKline
      • 12.7.1 GlaxoSmithKline Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Solid Tumor Therapeutics Introduction
      • 12.7.4 GlaxoSmithKline Revenue in Solid Tumor Therapeutics Business (2014-2019)
      • 12.7.5 GlaxoSmithKline Recent Development
    • 12.8 Eli Lilly
      • 12.8.1 Eli Lilly Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Solid Tumor Therapeutics Introduction
      • 12.8.4 Eli Lilly Revenue in Solid Tumor Therapeutics Business (2014-2019)
      • 12.8.5 Eli Lilly Recent Development
    • 12.9 Kyowa Hakko Kirin
      • 12.9.1 Kyowa Hakko Kirin Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Solid Tumor Therapeutics Introduction
      • 12.9.4 Kyowa Hakko Kirin Revenue in Solid Tumor Therapeutics Business (2014-2019)
      • 12.9.5 Kyowa Hakko Kirin Recent Development
    • 12.10 Abbott Laboratories
      • 12.10.1 Abbott Laboratories Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Solid Tumor Therapeutics Introduction
      • 12.10.4 Abbott Laboratories Revenue in Solid Tumor Therapeutics Business (2014-2019)
      • 12.10.5 Abbott Laboratories Recent Development
    • 12.11 Baxter International

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In cancer, solid tumors are formed by aggregation of abnormal tissues that do not comprise of any liquid or cyst.
      Increasing incidences of solid tumor among cancer patients and growing prevalence of various types of metastatic cancers are the major factors that are expected to drive the growth of the global solid tumor therapeutics market.
      In 2018, the global Solid Tumor Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Solid Tumor Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Solid Tumor Therapeutics development in United States, Europe and China.

      The key players covered in this study
      Hoffmann-La Roche
      Johnson & Johnson
      Novartis
      AstraZeneca
      Biogen Idec
      Boehringer Ingelheim
      GlaxoSmithKline
      Eli Lilly
      Kyowa Hakko Kirin
      Abbott Laboratories
      Baxter International

      Market segment by Type, the product can be split into
      Chemotherapy
      Hormone Therapy
      Immunotherapy
      Targeted Therapy

      Market segment by Application, split into
      Breast Cancer
      Lung Cancer
      Colorectal Cancer
      Prostate Cancer
      Cervical Cancer
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Solid Tumor Therapeutics status, future forecast, growth opportunity, key market and key players.
      To present the Solid Tumor Therapeutics development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Solid Tumor Therapeutics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now